白天和夜晚的唾液化物生物可用性,在用高或定期含的牙膏刷牙后
Guereth Carvalho1, Guilherme Santana1, Niciane Macena1
1Department of Restorative Dentistry, Federal University of Piaui, Teresina, Piauí, Brazil.
European journal of oral sciences
|March 5, 2026
概括
高化物牙膏显著提高了唾液化物的生物可用性,特别是在夜间刷牙时. 这种延长的化物保留表明,在睡眠前使用更高度时,牙保护得到了改善.
科学领域:
- 牙科 牙科是指牙科的专业.
- 化物研究 化物研究
- 生物化学 生物化学
背景情况:
- 唾液化物生物可用性对于预防牙损伤至关重要.
- 了解牙膏度和刷牙时间对化物保留的影响至关重要.
研究的目的:
- 为了比较高化物 (5000 ppm F) 和普通 (1450 ppm F) 牙膏之间的唾液化物生物可用性.
- 评估白天与夜间刷牙对化物保留的影响.
主要方法:
- 这是一项双盲交叉研究,涉及15名健康成年人.
- 在刷牙前后的多个时间点收集唾液.
- 使用离子选择性电极测量化物度.
主要成果:
- 两种牙膏都增加了唾液中的化物;高化物配方的度明显更高.
- 晚上用高化物牙膏刷牙,可以保持高化物水平长达8小时.
- 常规的牙膏化物水平在2小时内恢复到基线,无论刷牙时间如何.
结论:
- 化物的生物可用性在夜间期间更大,更持久.
- 刷牙时间显著影响唾液化物保留.
- 高化物牙膏可以更有效地提高化物的生物可用性和保留.
相关概念视频
Bioavailability Study Design: Absolute Versus Relative Bioavailability
484
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
484
Bioavailability Enhancement: Drug Solubility Enhancement
389
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
389
Modified-Release Drug Delivery Systems: Bioavailability
66
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
66
Salivary Glands and Saliva
2.8K
The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...
2.8K
Bioavailability: Overview
4.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.7K
Bioavailability: Overview
620
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
620


